Brooke Shields Flogs New Eyelash Growth Drug

I thought it was a joke when I saw the commercial. There was Brooke Shields telling me about the wonders of a drug called “Latisse”. We are told by Brooke and by the Latisse website that it is “the first and only prescription treatment approved by the FDA for inadequate or not having enough eyelashes”. I didn’t know that this was a problem. In the eyelash department I am one of the fortunate ones. Mine are long and full. But now these lashes are within the

Brooke Shields Before And After

reach of everyone. Everyone, that is, who wants to risk the possibility of changing their eye color (a slight but real side-effect), and pay about $130 a month. The effect of lengthening your lashes is not permanent, the eye color change (it could add brown pigment) is permanent.

Sadly people imagine that all kinds of physical things detract from their personhood. Lack of hair, color of hair, wrinkles, and now eyelash length to name a few. And, luckily for drug companies, they keep finding that the unintended consequences of some drugs (i. e. Side effects), help “solve” these perceived faults. Latisse is actually a low dose of Lumigan which is used to treat relieve increased eye pressure in glaucoma patients.

On the one hand these discoveries are good for the drug companies. They get to make money from an unexpected revenue source. And, I hope, some of the profit goes back into research. As for profit, it appears that they are charging about $50 more for a smaller dose. So the people who feel that they have inadequate eyelashes are making the manufacturer, Allergan, very happy.

As for Brooke Shields and her inadequate lashes, is there a difference, yes. Does it matter? I guess it does to her and others like her. And, unlike things like Botox, it doesn’t make you look like a lifeless fool.